AC
TENX icon

Armistice Capital’s Tenax Therapeutics TENX Stock Holding History

Armistice Capital’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-478,827
Closed -$7.66M – 412
2026
Q1 		$7.66M Buy
+478,827
New +$6.48M 0.14% 103
2022
Q4 		– Sell
-1,229
Closed -$334K – 233
2022
Q3 		$334K Buy
1,229
+231
+23% +$92.7K 0.01% 157
2022
Q2 		$479K Sell
998
-264
-21% -$264K 0.01% 137
2022
Q1 		$1.64M Hold
1,262
– – 0.03% 102
2021
Q4 		$2.1M Hold
1,262
– – 0.03% 121
2021
Q3 		$3.58M Hold
1,262
– – 0.06% 112
2021
Q2 		$4.2M Hold
1,262
– – 0.08% 96
2021
Q1 		$3.84M Hold
1,262
– – 0.09% 92
2020
Q4 		$3.76M Hold
1,262
– – 0.13% 88
2020
Q3 		$3.11M Buy
+1,262
New +$2.69M 0.11% 85
2020
Q2 		– Sell
-113
Closed -$104K – 92
2020
Q1 		$104K Buy
+113
New +$199K 0.01% 79
2019
Q1 		– Sell
-53
Closed -$102K – 85
2018
Q4 		$102K Buy
+53
New +$291K 0.01% 68
2016
Q4 		– Sell
-33
Closed -$2.47M – 55
2016
Q3 		$2.47M Sell
33
-2
-6% -$158K 0.79% 38
2016
Q2 		$2.84M Sell
35
-2
-5% -$167K 1.08% 37
2016
Q1 		$2.4M Buy
37
+6
+19% +$466K 0.94% 28
2015
Q4 		$3.25M Buy
31
+28
+933% +$2.9M 1.16% 27
2015
Q3 		$266K Buy
+3
New +$343K 0.09% 39

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Armistice Capital's TENX Position: Q2 2026 in Review

Armistice Capital sold out of Tenax Therapeutics (TENX) in Q2 2026, closing a stake of 478,827 shares — an estimated $7.66M sold.

Armistice Capital first reported a position in TENX in Q3 2015 and held it in 17 quarters. The position peaked at $7.66M in Q1 2026. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Armistice Capital reported no remaining Tenax Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Armistice Capital sold 478,827 Tenax Therapeutics shares in Q2 2026, an estimated $7.66M.
  • Armistice Capital first reported a position in Tenax Therapeutics in Q3 2015 and held it in 17 quarters.
  • Armistice Capital's Tenax Therapeutics position peaked at $7.66M in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.